Jonathan E H Ling1,2, Timothy Coughlan3, Kevan R Polkinghorne4,5,6, John Kanellis4,5. 1. Department of Nephrology, Monash Medical Centre, Monash Health, 246 Clayton Road, Clayton, Melbourne, VIC, 3168, Australia. jlingeh@gmail.com. 2. Centre for Inflammatory Diseases, Department of Medicine, Monash University, Clayton, Melbourne, Australia. jlingeh@gmail.com. 3. Department of Renal Services, Latrobe Regional Hospital, Victoria, Australia. 4. Department of Nephrology, Monash Medical Centre, Monash Health, 246 Clayton Road, Clayton, Melbourne, VIC, 3168, Australia. 5. Centre for Inflammatory Diseases, Department of Medicine, Monash University, Clayton, Melbourne, Australia. 6. Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Prahran, Melbourne, Australia.
Abstract
BACKGROUND: Risk indices such as the pancreas donor risk index (PDRI) and pre-procurement pancreas allocation suitability score (P-PASS) are utilised in solid pancreas transplantation however no review has compared all derived and validated indices in this field. We systematically reviewed all risk indices in solid pancreas transplantation to compare their predictive ability for transplant outcomes. METHODS: Medline Plus, Embase and the Cochrane Library were searched for studies deriving and externally validating risk indices in solid pancreas transplantation for the outcomes of pancreas and patient survival and donor pancreas acceptance for transplantation. Results were analysed descriptively due to limited reporting of discrimination and calibration metrics required to assess model performance. RESULTS: From 25 included studies, discrimination and calibration metrics were only reported in 88% and 38% of derivation studies (n = 8) and in 25% and 25% of external validation studies (n = 12) respectively. 21 risk indices were derived with mild to moderate ability to predict risk (C-statistics 0.52-0.78). Donor age, donor body mass index (BMI) and donor gender were the commonest covariates within derived risk indices. Only PDRI and P-PASS were subsequently externally validated, with variable association with post-transplant outcomes. P-PASS was not associated with pancreas graft survival. CONCLUSION: Most of the risk indices derived for use in solid pancreas transplantation were not externally validated (90%). PDRI and P-PASS are the only risk indices externally validated for solid pancreas transplantation, and when validated without reclassification measures, are associated with 1-year pancreas graft survival and donor pancreas acceptance respectively. Future risk indices incorporating recipient and other covariates alongside donor risk factors may have improved predictive ability for solid pancreas transplant outcomes.
BACKGROUND: Risk indices such as the pancreas donor risk index (PDRI) and pre-procurement pancreas allocation suitability score (P-PASS) are utilised in solid pancreas transplantation however no review has compared all derived and validated indices in this field. We systematically reviewed all risk indices in solid pancreas transplantation to compare their predictive ability for transplant outcomes. METHODS: Medline Plus, Embase and the Cochrane Library were searched for studies deriving and externally validating risk indices in solid pancreas transplantation for the outcomes of pancreas and patient survival and donor pancreas acceptance for transplantation. Results were analysed descriptively due to limited reporting of discrimination and calibration metrics required to assess model performance. RESULTS: From 25 included studies, discrimination and calibration metrics were only reported in 88% and 38% of derivation studies (n = 8) and in 25% and 25% of external validation studies (n = 12) respectively. 21 risk indices were derived with mild to moderate ability to predict risk (C-statistics 0.52-0.78). Donor age, donor body mass index (BMI) and donor gender were the commonest covariates within derived risk indices. Only PDRI and P-PASS were subsequently externally validated, with variable association with post-transplant outcomes. P-PASS was not associated with pancreas graft survival. CONCLUSION: Most of the risk indices derived for use in solid pancreas transplantation were not externally validated (90%). PDRI and P-PASS are the only risk indices externally validated for solid pancreas transplantation, and when validated without reclassification measures, are associated with 1-year pancreas graft survival and donor pancreas acceptance respectively. Future risk indices incorporating recipient and other covariates alongside donor risk factors may have improved predictive ability for solid pancreas transplant outcomes.
Entities:
Keywords:
Organ acceptance; Pancreas; Risk; Risk index; Survival; Transplantation
Authors: Karel G M Moons; Andre Pascal Kengne; Diederick E Grobbee; Patrick Royston; Yvonne Vergouwe; Douglas G Altman; Mark Woodward Journal: Heart Date: 2012-03-07 Impact factor: 5.994
Authors: Howard Balshem; Mark Helfand; Holger J Schünemann; Andrew D Oxman; Regina Kunz; Jan Brozek; Gunn E Vist; Yngve Falck-Ytter; Joerg Meerpohl; Susan Norris; Gordon H Guyatt Journal: J Clin Epidemiol Date: 2011-01-05 Impact factor: 6.437
Authors: B L Kasiske; S Gustafson; N Salkowski; P G Stock; D A Axelrod; R Kandaswamy; E F Sleeman; J Wainright; A K Israni; J J Snyder Journal: Am J Transplant Date: 2013-01-07 Impact factor: 8.086
Authors: E B Finger; D M Radosevich; T B Dunn; S Chinnakotla; D E R Sutherland; A J Matas; T L Pruett; R Kandaswamy Journal: Am J Transplant Date: 2013-05-24 Impact factor: 8.086
Authors: Kaja Śmigielska; Paweł Skrzypek; Jarosław Czerwiński; Grzegorz Michalak; Marek Durlik; Tadeusz Grochowiecki; Sławomir Nazarewski; Jacek Szmidt; Jacek Ziaja; Robert Król; Lech Cierpka; Wojciech Lisik; Maciej Kosieradzki Journal: Ann Transplant Date: 2018-05-25 Impact factor: 1.530